The Board of Directors of Gpi examined today the preliminary consolidated results for 2021.
- FY2021 REVENUE of around €326 M (FY2020: €271 M)
- FY2021 EBITDA of around €50 M (FY2020: €40 M)
- FY2021 NFD of around €158 M (FY2020: €145 M)
Fausto Manzana, Gpi’s Chairman and CEO, commented:
“Preliminary data bear witness to the Gpi Group’s continuing progress in 2021: an important sign, which makes us confident in the future. Over the past 2 years, marked by the pandemic, we have managed not only to stay strong and safe, but also to grow beyond our expectations. The central role played by health in the resilience of countries’ socioeconomic systems has highlighted the potential for sustainability that characterizes our health care vision and offerings. We have been rewarded. A great challenge lies ahead of us in the coming years: unprecedented resources are available to reform health systems, overhaul community health care by putting citizens at the centre and ensure equitable access to care. We are ready.”